SPRY1 and obesity due to melanocortin 4 receptor deficiency: Loss of SPRY1 has been associated with metabolic disorders, such as metabolic syndrome, diabetes, and obesity, with a phenotype characterized by excessive adipogenesis and reduced bone mass (47).